Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals

NCT03785106 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

HIV-infected Participants With Latent TB Infection in High TB Burden Country

Interventions

DRUG: Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
DRUG: Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]